398 related articles for article (PubMed ID: 25440591)
1. Visceral adiposity and the risk of metabolic syndrome across body mass index: the MESA Study.
Shah RV; Murthy VL; Abbasi SA; Blankstein R; Kwong RY; Goldfine AB; Jerosch-Herold M; Lima JA; Ding J; Allison MA
JACC Cardiovasc Imaging; 2014 Dec; 7(12):1221-35. PubMed ID: 25440591
[TBL] [Abstract][Full Text] [Related]
2. Abdominal fat radiodensity, quantity and cardiometabolic risk: The Multi-Ethnic Study of Atherosclerosis.
Shah RV; Allison MA; Lima JA; Abbasi SA; Eisman A; Lai C; Jerosch-Herold M; Budoff M; Murthy VL
Nutr Metab Cardiovasc Dis; 2016 Feb; 26(2):114-22. PubMed ID: 26817938
[TBL] [Abstract][Full Text] [Related]
3. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
4. Ultrasound-assessed visceral fat and associations with glucose homeostasis and cardiovascular risk in clinical practice.
Bellan M; Menegatti M; Ferrari C; Carnevale Schianca GP; Pirisi M
Nutr Metab Cardiovasc Dis; 2018 Jun; 28(6):610-617. PubMed ID: 29656956
[TBL] [Abstract][Full Text] [Related]
5. Body adiposity indicators and cardiometabolic risk: Cross-sectional analysis in participants from the PREDIMED-Plus trial.
Konieczna J; Abete I; Galmés AM; Babio N; Colom A; Zulet MA; Estruch R; Vidal J; Toledo E; Díaz-López A; Fiol M; Casas R; Vera J; Buil-Cosiales P; Martín V; Goday A; Salas-Salvadó J; Martínez JA; Romaguera D;
Clin Nutr; 2019 Aug; 38(4):1883-1891. PubMed ID: 30031660
[TBL] [Abstract][Full Text] [Related]
6. Sensitivity of various adiposity indices in identifying cardiometabolic diseases in Arab adults.
Al-Daghri NM; Al-Attas OS; Wani K; Alnaami AM; Sabico S; Al-Ajlan A; Chrousos GP; Alokail MS
Cardiovasc Diabetol; 2015 Aug; 14():101. PubMed ID: 26249167
[TBL] [Abstract][Full Text] [Related]
7. Assessing the usefulness of a newly proposed metabolic score for visceral fat in predicting future diabetes: results from the NAGALA cohort study.
Yang R; Kuang M; Qiu J; Yu C; Sheng G; Zou Y
Front Endocrinol (Lausanne); 2023; 14():1172323. PubMed ID: 37538796
[TBL] [Abstract][Full Text] [Related]
8. Gender differences in the association of visceral and subcutaneous adiposity with adiponectin in African Americans: the Jackson Heart Study.
Bidulescu A; Liu J; Hickson DA; Hairston KG; Fox ER; Arnett DK; Sumner AE; Taylor HA; Gibbons GH
BMC Cardiovasc Disord; 2013 Feb; 13():9. PubMed ID: 23433085
[TBL] [Abstract][Full Text] [Related]
9. Is Metabolic Score for Visceral Fat (METS-VF) a Better Index Than Other Adiposity Indices for the Prediction of Visceral Adiposity.
Torun C; Ankaralı H; Caştur L; Uzunlulu M; Erbakan AN; Akbaş MM; Gündüz N; Doğan MB; Oğuz A
Diabetes Metab Syndr Obes; 2023; 16():2605-2615. PubMed ID: 37663201
[TBL] [Abstract][Full Text] [Related]
10. The Role of Visceral Adiposity Index Levels in Predicting the Presence of Metabolic Syndrome and Insulin Resistance in Overweight and Obese Patients.
Pekgor S; Duran C; Berberoglu U; Eryilmaz MA
Metab Syndr Relat Disord; 2019 Jun; 17(5):296-302. PubMed ID: 30932744
[No Abstract] [Full Text] [Related]
11. Visceral obesity, but not central obesity, is associated with cardiac remodeling in subjects with suspected metabolic syndrome.
Cho DH; Kim MN; Joo HJ; Shim WJ; Lim DS; Park SM
Nutr Metab Cardiovasc Dis; 2019 Apr; 29(4):360-366. PubMed ID: 30782509
[TBL] [Abstract][Full Text] [Related]
12. Metabolic Score for Visceral Fat (METS-VF), a novel estimator of intra-abdominal fat content and cardio-metabolic health.
Bello-Chavolla OY; Antonio-Villa NE; Vargas-Vázquez A; Viveros-Ruiz TL; Almeda-Valdes P; Gomez-Velasco D; Mehta R; Elias-López D; Cruz-Bautista I; Roldán-Valadez E; Martagón AJ; Aguilar-Salinas CA
Clin Nutr; 2020 May; 39(5):1613-1621. PubMed ID: 31400997
[TBL] [Abstract][Full Text] [Related]
13. DXA-Derived vs Standard Anthropometric Measures for Predicting Cardiometabolic Risk in Middle-Aged Australian Men and Women.
Zhu K; Walsh JP; Murray K; Hunter M; Hui J; Hung J
J Clin Densitom; 2022; 25(3):299-307. PubMed ID: 35177350
[TBL] [Abstract][Full Text] [Related]
14. Associations of visceral and liver fat with the metabolic syndrome across the spectrum of obesity: the AGES-Reykjavik study.
Kim LJ; Nalls MA; Eiriksdottir G; Sigurdsson S; Launer LJ; Koster A; Chaves PH; Jonsdottir B; Garcia M; Gudnason V; Harris TB;
Obesity (Silver Spring); 2011 Jun; 19(6):1265-71. PubMed ID: 21183935
[TBL] [Abstract][Full Text] [Related]
15. Pericardial, But Not Hepatic, Fat by CT Is Associated With CV Outcomes and Structure: The Multi-Ethnic Study of Atherosclerosis.
Shah RV; Anderson A; Ding J; Budoff M; Rider O; Petersen SE; Jensen MK; Koch M; Allison M; Kawel-Boehm N; Wisocky J; Jerosch-Herold M; Mukamal K; Lima JAC; Murthy VL
JACC Cardiovasc Imaging; 2017 Sep; 10(9):1016-1027. PubMed ID: 28330662
[TBL] [Abstract][Full Text] [Related]
16. The Impact of Blood Pressure and Visceral Adiposity on the Association of Serum Uric Acid With Albuminuria in Adults Without Full Metabolic Syndrome.
Krajcoviechova A; Tremblay J; Wohlfahrt P; Bruthans J; Tahir MR; Hamet P; Cifkova R
Am J Hypertens; 2016 Dec; 29(12):1335-1342. PubMed ID: 27565787
[TBL] [Abstract][Full Text] [Related]
17. The relationship between DXA-based and anthropometric measures of visceral fat and morbidity in women.
Direk K; Cecelja M; Astle W; Chowienczyk P; Spector TD; Falchi M; Andrew T
BMC Cardiovasc Disord; 2013 Apr; 13():25. PubMed ID: 23552273
[TBL] [Abstract][Full Text] [Related]
18. Metabolic Score for Visceral Fat: A reliable indicator of visceral obesity for predicting risk for hypertension.
Feng Y; Yang X; Li Y; Wu Y; Han M; Qie R; Huang S; Wu X; Zhang Y; Liu D; Hu F; Zhang M; Yang Y; Shi X; Lu J; Zhao Y; Hu D
Nutrition; 2022 Jan; 93():111443. PubMed ID: 34563934
[TBL] [Abstract][Full Text] [Related]
19. Overweight modifies the longitudinal association between uric acid and some components of the metabolic syndrome: The Tromsø Study.
Norvik JV; Storhaug HM; Ytrehus K; Jenssen TG; Zykova SN; Eriksen BO; Solbu MD
BMC Cardiovasc Disord; 2016 May; 16():85. PubMed ID: 27165776
[TBL] [Abstract][Full Text] [Related]
20. Effects of magnitude of visceral adipose tissue reduction: Impact on insulin resistance, hyperleptinemia and cardiometabolic risk in adolescents with obesity after long-term weight-loss therapy.
Campos RMDS; Masquio DCL; Corgosinho FC; Caranti DA; Ganen AP; Tock L; Oyama LM; Dâmaso AR
Diab Vasc Dis Res; 2019 Mar; 16(2):196-206. PubMed ID: 30688518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
